Tigecycline : A critical analysisSTEIN, Gary E; CRAIG, William A.Clinical infectious diseases. 2006, Vol 43, Num 4, pp 518-524, issn 1058-4838, 7 p.Article

Tigecycline : A novel broad-spectrum antimicrobialSLOVER, Christine M; RODVOLD, Keith A; DANZIGER, Larry H et al.The Annals of pharmacotherapy. 2007, Vol 41, Num 6, pp 965-972, issn 1060-0280, 8 p.Article

Tigecycline : A single antibiotic for polymicrobial infectionsPANKEY, George A; STEELE, Russell W.The Pediatric infectious disease journal. 2007, Vol 26, Num 1, pp 77-78, issn 0891-3668, 2 p.Article

Effect of tigecycline on normal oropharyngeal and intestinal microfloraNORD, Carl Erik; SILLERSTRÖM, Eva; WAHLUND, Elisabeth et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 10, pp 3375-3380, issn 0066-4804, 6 p.Article

The pharmacokinetic and pharmacodynamic profile of tigecyclineMEAGHER, Alison K; AMBROSE, Paul G; GRASELA, Thaddeus H et al.Clinical infectious diseases. 2005, Vol 41, Num 5, pp S333-S340, issn 1058-4838, SUPArticle

Functional, biophysical, and structural bases for antibacterial activity of tigecyclineOLSON, Matthew W; RUZIN, Alexey; FEYFANT, Eric et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 6, pp 2156-2166, issn 0066-4804, 11 p.Article

Tigecycline : A new glycylcycline for treatment of serious infectionsNOSKIN, Gary A.Clinical infectious diseases. 2005, Vol 41, Num 5, pp S303-S314, issn 1058-4838, SUPArticle

Tigecycline : what is it, and where should it be used?LIVERMORE, David M.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 4, pp 611-614, issn 0305-7453, 4 p.Article

Exposure-response analyses of tigecycline efficacy in patients with complicated skin and skin-structure infectionsMEAGHER, A. K; PASSARELL, J. A; CIRINCIONE, B. B et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 1939-1945, issn 0066-4804, 7 p.Article

Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocyclineFLUIT, Ad C; FLORIJN, Alice; VERHOEF, Jan et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 4, pp 1636-1638, issn 0066-4804, 3 p.Article

Tigecycline : The answer to beta-lactam and fluoroquinolone resistance?FRAISE, Adam P.The Journal of infection. 2006, Vol 53, Num 5, pp 293-300, issn 0163-4453, 8 p.Article

Peritoneal fluid penetration of tigecyclineSCHEETZ, Marc H; REDDY, Pavani; NICOLAU, David P et al.The Annals of pharmacotherapy. 2006, Vol 40, Num 11, pp 2064-2067, issn 1060-0280, 4 p.Article

TigecyclinePANKEY, George A.Journal of antimicrobial chemotherapy (Print). 2005, Vol 56, Num 3, pp 470-480, issn 0305-7453, 11 p.Article

Evaluation of tigecycline penetration into colon wall tissue and epithelial lining fluid using a population pharmacokinetic model and Monte Carlo simulationRUBINO, Christopher M; LEI MA; BHAVNANI, Sujata M et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 11, pp 4085-4089, issn 0066-4804, 5 p.Article

AcrAB efflux pump plays a role in decreased susceptibility to tigecycline in Morganella morganiiRUZIN, Alexey; KEENEY, David; BRADFORD, Patricia A et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 2, pp 791-793, issn 0066-4804, 3 p.Article

Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniaeRUZIN, Alexey; VISALLI, Melissa A; KEENEY, David et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 3, pp 1017-1022, issn 0066-4804, 6 p.Article

In vitro activities of tigecycline against the Bacteroides fragilis groupJACOBUS, N. V; MCDERMOTT, L. A; RUTHAZER, R et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 3, pp 1034-1036, issn 0066-4804, 3 p.Article

Steady-state serum and intrapulmonary pharmacokinetics and pharmacodynamics of tigecyclineCONTE, John E; GOLDEN, Jeffrey A; KELLY, Mary Grace et al.International journal of antimicrobial agents. 2005, Vol 25, Num 6, pp 523-529, issn 0924-8579, 7 p.Article

Tigecycline : A review of a new glycylcycline antibioticSCHEINFELD, Noah.Journal of dermatological treatment. 2005, Vol 16, Num 4, pp 207-212, issn 0954-6634, 6 p.Article

The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections : Analysis of pooled clinical trial dataBABINCHAK, Timothy; ELLIS-GROSSE, Evelyn; DARTOIS, Nathalie et al.Clinical infectious diseases. 2005, Vol 41, Num 5, pp S354-S366, issn 1058-4838, SUPArticle

Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumanniiPELEG, Anton Y; ADAMS, Jennifer; PATERSON, David L et al.Antimicrobial agents and chemotherapy. 2007, Vol 51, Num 6, pp 2065-2069, issn 0066-4804, 5 p.Article

Population pharmacokinetics of tigecycline in patients with complicated intra-abdominal or skin and skin structure infectionsVAN WART, S. A; OWEN, J. S; LUDWIG, E. A et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 11, pp 3701-3707, issn 0066-4804, 7 p.Article

Effects of age and sex on single-dose pharmacokinetics of tigecycline in healthy subjectsMURALIDHARAN, Gopal; FRUNCILLO, Richard J; MICALIZZI, Marlynne et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 4, pp 1656-1659, issn 0066-4804, 4 p.Article

Antibiotic coresistance in extended-spectrum-β-lactamase-producing Enterobacteriaceae and in vitro activity of tigecyclineMOROSINI, Maria-Isabel; GARCIA-CASTILLO, Maria; COQUE, Teresa M et al.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 8, pp 2695-2699, issn 0066-4804, 5 p.Article

In vitro activity of tigecycline against Burkholderia pseudomallei and Burkholderia thailandensisTHAMLIKITKUL, Visanu; TRAKULSOMBOON, Suwanna.Antimicrobial agents and chemotherapy. 2006, Vol 50, Num 4, pp 1555-1557, issn 0066-4804, 3 p.Article